[ARWR] QoQ Quarter Result on 30-Sep-2020 [#Q4]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
23-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q4]
Profit Trend
QoQ- -255.84%
YoY- -513.78%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 45,891 32,811 21,303 7,633 27,376 23,529 29,455 34.43%
PBT -29,924 -26,818 -20,732 -48,430 -13,611 -19,836 -2,674 401.04%
Tax -1,280 -1,524 -2,169 2 0 0 1 -
NP -29,924 -26,818 -20,732 -48,433 -13,611 -19,836 -2,674 401.04%
Tax Rate - - - - - - - -
Total Cost 75,815 59,629 42,035 56,066 40,987 43,364 32,128 77.34%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -65.21 -81.73 -97.32 -634.53 -49.72 -84.30 -9.08 272.68%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -0.29 -0.26 -0.20 -0.47 -0.13 -0.20 -0.03 354.41%
EPS Diluted -0.29 -0.26 -0.20 -0.47 -0.13 -0.20 -0.03 354.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.